open access
메뉴
open access
메뉴
ISSN : 0376-4672
In recent years, many researchers and clinicians found interest in regenerative medicine using induced pluripotent stem cells (iPSCs) with biomaterials due to their pluripotency, which is able to differentiate into any type of cells without human embryo, which of use is ethically controversial. However, there are limitations to make iPSCs from adult somatic cells due to their low stemness and donor site morbidity. Recently, to overcome above drawbacks, dental tissue-derived iPSCs have been highlighted as a type of alternative sources for their high stemness, easy gathering, and their complex (ectomesenchymal) origin, which easily differentiate them to various cell types for nerve, vessel, and other dental tissue regeneration. In other part, utilizing biomaterials for regenerative medicine using cell is recently highlighted because they can modulate cell adhesion, proliferation and (de)differentiation. Therefore, this paper will convey the overview of advantages and drawbacks of dental tissue-derived iPSCs and their future application with biomaterials.
1. Yamanaka S. Induced pluripotent stemcells: past, present, and future. Cell Stem Cell 2012; 10(6):678-684
2. Kriks S, Shim JW, Piao J, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature 2011; 480(7378):547-551
3. Takayama N, Nishimura S, Nakamura S, et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 2010; 207(13):2817-2830
4. Nori S, Okada Y, Yasuda A, et al. Grafted humaninduced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A 2011; 108(40):16825-16830
5. Okamoto S, Takahashi M. Induction of retinal pigment epithelial cells from monkey iPS cells. Invest Ophthalmol Vis Sci 2011; 52(12):8785-8790
6. Kunisada Y, Tsubooka-Yamazoe N, Shoji M, Hosoya M. Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells. Stem Cell Res 2012; 8(2):274-284
7. Srijaya TC, Pradeep PJ, Zain RB, et al. The promise of human induced pluripotent stem cells in dental research. Stem Cells Int 2012; 2012:423868
8. Yan X, Qin H, Qu C, et al. iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev 2010; 19(4):469-480
9. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4):663-676
10. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131(5):861-872
11. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318(5858):1917-1920
12. Aasen T, Raya A, Barrero MJ, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature biotechnology 2008; 26(11):1276-1284
13. Kang R, Zhou Y, Tan S, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Research & Therapy 2015; 6(1):144
14. Hynes K, Menichanin D, Bright R, et al. Induced Pluripotent Stem Cells: A New Frontier for Stem Cells in Dentistry. J Dent Res 2015; 94(11):1508-1515
15. Yoo CH, Na HJ, Lee DS, et al. Endothelial progenitor cells from human dental pulp-derived iPS cells as a therapeutic target for ischemic vascular diseases. Biomaterials 2013; 34(33):8149-8160
16. Chen J, Lin M, Foxe JJ, et al. Transcriptome comparison of human neurons generated using induced pluripotent stem cells derived from dental pulp and skin fibroblasts. PLoS One 2013; 8(10):e75682
17. Crowder SW, Leonardo V, Whittaker T, et al. Material Cues as Potent Regulators of Epigenetics and Stem Cell Function. Cell Stem Cell 2016; 18(1):39-52
18. Perez RA, Choi S-J, Han C-M, et al. Biomaterials control of pluripotent stem cell fate for regenerative therapy. Progress in Materials Science 2016; 82:234-293
19. Lee J-H, Seo S-J. Biomedical Application of Dental Tissue-Derived Induced Pluripotent Stem Cells. Stem Cells International 2016; 2016:7
20. Perez RA, Kim H-W. Core-shell designed scaffolds for drug delivery and tissue engineering. Acta Biomaterialia 2015; 21:2-19
21. Kim HW, Song JH, Kim HE. Nanofiber Generation of Gelatin?Hydroxyapatite Biomimetics for Guided Tissue Regeneration. Advanced Functional Materials 2005; 15(12):1988-1994
22. Gurdon JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 1962; 10:622-640
23. Wilmut I, Schnieke AE, McWhir J, et al. Viable offspring derived from fetal and adult mammalian cells. Cloning Stem Cells 2007; 9(1):3-7
24. Tada M, Takahama Y, Abe K, et al. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 2001; 11(19):1553-1558
25. Schneuwly S, Klemenz R, Gehring WJ. Redesigning the body plan of Drosophila by ectopic expression of the homoeotic gene Antennapedia. Nature 1987; 325(6107):816-818
26. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987; 51(6):987-1000
27. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292(5819):154-156
28. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391):1145-1147
29. Nayak S, Herzog RW. Progress and prospects:immune responses to viral vectors. Gene Ther 2010; 17(3):295-304
30. Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008; 321(5889):699-702
31. Okita K, Nakagawa M, Hyenjong H, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322(5903):949-953
32. Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7(5):618-630
33. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4(6):472-476
34. Fusaki N, Ban H, Nishiyama A, et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 2009; 85(8):348-362
35. Miyoshi N, Ishii H, Nagano H, et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011; 8(6):633-638
36. Montserrat N, Garreta E, Gonzalez F, et al. Simple generation of human induced pluripotent stem cells using poly-beta-amino esters as the non-viral gene delivery system. J Biol Chem 2011; 286(14):12417-12428
37. Lee CH, Kim JH, Lee HJ, et al. The generation of iPS cells using non-viral magnetic nanoparticle based transfection. Biomaterials 2011; 32(28):6683-6691
38. Zhu K, Li J, Lai H, et al. Reprogramming fibroblasts to pluripotency using arginine-terminated polyamidoamine nanoparticles based non-viral gene delivery system. Int J Nanomedicine 2014; 9:5837-5847
39. Sohn YD, Somasuntharam I, Che PL, et al. Induction of pluripotency in bone marrow mononuclear cells via polyketal nanoparticlemediated delivery of mature microRNAs. Biomaterials 2013; 34(17):4235-4241
40. Khan M, Narayanan K, Lu H, et al. Delivery of reprogramming factors into fibroblasts for generation of non-genetic induced pluripotent stem cells using a cationic bolaamphiphile as a non-viral vector. Biomaterials 2013; 34(21):5336-5343
41. Baek S, Quan X, Kim S, et al. Electromagnetic fields mediate efficient cell reprogramming into a pluripotent state. ACS Nano 2014; 8(10):10125-10138
42. Yoo J, Kim J, Baek S, et al. Cell reprogramming into the pluripotent state using graphene based substrates. Biomaterials 2014; 35(29):8321-8329
43. Potdar PD, Jethmalani YD. Human dental pulp stem cells: Applications in future regenerative medicine. World Journal of Stem Cells 2015; 7(5):839-851
44. Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 2011; 9(1):17-23
45. Nashun B, Hill PW, Hajkova P. Reprogramming of cell fate: epigenetic memory and the erasure of memories past. Embo j 2015; 34(10):1296-1308
46. Chang YC, Li WC, Twu NF, et al. Induction of dental pulp-derived induced pluripotent stem cells in the absence of c-Myc for differentiation into neuron-like cells. J Chin Med Assoc 2014; 77(12):618-625
47. I.-H. Park NA, H. Huo et al. Disease-specific induced pluripotent stem cells Cell Stem Cell 2008; 134(5):877-886
48. Raab S, Klingenstein M. A Comparative View on Human Somatic Cell Sources for iPSC Generation. 2014; 2014:768391
49. Nori S, Okada Y, Nishimura S, et al. Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition. Stem Cell Reports 2015; 4(3):360-373
50. X. Cao WD, R. Qu et al. Non-viral co-delivery of the four yamanaka factors for generation of human induced pluripotent stem cells via calcium phosphate nanocomposite particles. Advanced Functional Materials 2013; 23(43):5403-5411
51. Zhao Q, Gregory CA, Lee RH, et al. MSCs derived from iPSCs with a modified protocol are tumortropic but have much less potential to promote tumors than bone marrow MSCs. Proc Natl Acad Sci U S A 2015; 112(2):530-535
52. Erickson GA, Bolin SR, Landgraf JG. Viral contamination of fetal bovine serum used for tissue culture: risks and concerns. Dev Biol Stand 1991; 75:173-175
53. Takeda-Kawaguchi T, Sugiyama K, Chikusa S, et al. Derivation of iPSCs after culture of human dental pulp cells under defined conditions. PLoS One 2014; 9(12):e115392
54. Gandia C, Arminan A, Garcia-Verdugo JM, et al. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells 2008; 26(3):638-645
55. Mannello F, Tonti GA. Concise Review: No Breakthroughs for Human Mesenchymal and Embryonic Stem Cell Culture: Conditioned Medium, Feeder Layer, or Feeder?Free; Medium with Fetal Calf Serum, Human Serum, or Enriched Plasma; Serum?Free, Serum Replacement Nonconditioned Medium, or Ad Hoc Formula? All That Glitters Is Not Gold! Stem cells 2007; 25(7):1603-1609
56. Tamaoki N, Takahashi K, Tanaka T, et al. Dental pulp cells for induced pluripotent stem cell banking. Journal of dental research 2010; 89(8):773-778
57. Szabo E, Rampalli S, Risueno RM, et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010; 468(7323):521-526
58. Sekiya S, Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011; 475(7356):390-393
59. Nosrat IV, Widenfalk J, Olson L, Nosrat CA. Dental pulp cells produce neurotrophic factors, interact with trigeminal neurons in vitro, and rescue motoneurons after spinal cord injury. Dev Biol 2001; 238(1):120-132
60. Graziano A, d’Aquino R, Laino G, Papaccio G. Dental pulp stem cells: a promising tool for bone regeneration. Stem Cell Rev 2008; 4(1):21-26
61. Ballester-Beltran J, Cantini M, Lebourg M, et al. Effect of topological cues on material-driven fibronectin fibrillogenesis and cell differentiation. Journal of Materials Science: Materials in Medicine 2012; 23(1):195-204
62. Yoo J, Noh M, Kim H, et al. Nanogrooved substrate promotes direct lineage reprogramming of fibroblasts to functional induced dopaminergic neurons. Biomaterials 2015; 45:36-45
63. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55(3):329-347
64. Gilbert PM, Havenstrite KL, Magnusson KE, et al. Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 2010; 329(5995):1078-1081